期刊文献+

肝纤维化中西医结合治疗进展与发展方向 被引量:3

Progress and perspectives for the treatment of liver fibrosis with integrative medicines
原文传递
导出
摘要 肝纤维化是各种慢性肝病的共同病理特征,有效治疗肝纤维化对于改善慢性肝病预后,降低慢性肝病病死率至关重要。本文就慢性肝炎抗纤维化必要性、中医药及中西医结合抗肝纤维化发展与现状以及中医药抗肝纤维化研究的发展方向等进行回顾与评述,旨在为推进我国中西医结合抗肝纤维化事业的发展提供思路。 The liver fibrosis is the common pathological feature for most chronic liver diseases,and the effective treatment of liver fibrosis can improve the prognosis of chronic liver diseases and decrease the mortality due to liver diseases.The article highlights the necessities,reviews the development progresses and current situation of anti-liver fibrosis investigations with traditional Chinese medicine and integrative medicine,and discusses the development prospective in the filed.The authors try to provide some ideas and references for the academic development of anti-liver fibrosis with integrative medicine.
出处 《中华消化病与影像杂志(电子版)》 2014年第6期1-4,共4页 Chinese Journal of Digestion and Medical Imageology(Electronic Edition)
关键词 肝纤维化 医学 中国传统 现代医学 Liver cirrhosis Medicine,Chinese traditional Modern medicine
  • 相关文献

参考文献7

二级参考文献87

共引文献206

同被引文献31

  • 1中华医学会肝病学分会脂肪肝和酒精性肝病学组.酒精性肝病诊疗指南[J].中国肝脏病杂志(电子版),2010,2(4):49-53. 被引量:385
  • 2张琴,刘平,章浩伟,王磊,都广礼,陈慧芬,陈良,王江容,王宪波.900例肝炎后肝硬化中医证候判别模式的研究[J].中国中西医结合杂志,2006,26(8):694-697. 被引量:63
  • 3Friedman SL.Mechanisms of disease:mechanisms of hepatic fibrosis and therapeutic implications[J].Nat Clin Pract Gastroenterol Hepatol,2004,1(2):98.
  • 4Kisseleva T,Brenner DA.Anti-fibrogenic strategies and the regression of fibrosis[J].Best Pract Res Clin Gastroenterol,2011,25(2):305-317.
  • 5Nakao A,Afrakhte M,Moren A,et al.Identification of Smad7,a TGFbeta-inducible antagonist of TGF-beta signalling[J].Nature,1997,389(6651):631-635.
  • 6Argentou N,Germanidis G,Hytiroglou P,et al.TGF-βsignaling is activated in patients with chronic HBV infection and repressed by SMAD7 overexpression after successful antiviral treatment[J].Inflamm Res,2016,65(5):355-365.
  • 7Yoon YJ,Friedman SL,Lee YA.Antifibrotic Therapies:Where Are We Now?[J].Semin Liver Dis,2016,36(1):87-98.
  • 8Du JX,Sun MY,Du GL,et al.Ingredients of Huangqi decoction slow biliary fibrosis progression by inhibiting the activation of transforming growth factor beta signaling pathway[J].BMC Complement Altern Med,2012,12(1):33.
  • 9雷娜,郑仕中,陆茵.活血化瘀类中药防治肝纤维化的机制及研究进展[J].中华中医药杂志,2010,25(2):265-268. 被引量:50
  • 10杜琴,胡兵,沈克平.抗癌中药配伍研究[J].中国实验方剂学杂志,2010,16(13):232-235. 被引量:28

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部